Skip to main content
. Author manuscript; available in PMC: 2022 Mar 14.
Published in final edited form as: J Biophotonics. 2021 May 4;14(7):e202100073. doi: 10.1002/jbio.202100073

Table 3.

Results of primary endpoint

Treatment Group Treatment or Control Side Time Point Median Percent Change ([Baseline – 6 month]/Baseline)
SkinFibroMeter (N) Group 1 Treatment Baseline 0.08 ↓62.5
6 month 0.03
Control Baseline 0.05 ↓40.0
6 month 0.03
Group 2 Treatment Baseline 0.09 ↓77.8
6 month 0.02
Control Baseline 0.06 ↓50.0
6 month 0.03
Group 3 Treatment Baseline 0.06 ↓50.0
6 month 0.03
Control Baseline 0.07 ↓71.4
6 month 0.02